935 related articles for article (PubMed ID: 30970294)
1. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J
Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
Guo D; Wang Y; Ren K; Han X
Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MALAT1 Depressed Chemo-Sensitivity of NSCLC Cells through Directly Functioning on miR-197-3p/p120 Catenin Axis.
Yang T; Li H; Chen T; Ren H; Shi P; Chen M
Mol Cells; 2019 Mar; 42(3):270-283. PubMed ID: 30841025
[TBL] [Abstract][Full Text] [Related]
4. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
Qi G; Li L
Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
Wei S; Wang K; Huang X; Zhao Z; Zhao Z
Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
Dong Z; Liu H; Zhao G
Cancer Biother Radiopharm; 2020 Jun; 35(5):351-361. PubMed ID: 32202941
[No Abstract] [Full Text] [Related]
8. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.
Huang M; Liao X; Li L; Li G; Chen M
Tissue Cell; 2021 Dec; 73():101672. PubMed ID: 34736163
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
Yu L; Chen D; Song J
Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
Zhao L; Bi M; Zhang H; Shi M
Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
[No Abstract] [Full Text] [Related]
11. The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis.
Li S; Mei Z; Hu HB; Zhang X
J Cell Physiol; 2018 Sep; 233(9):6679-6688. PubMed ID: 29215698
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
16. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
17. MYPT1, regulated by miR-19b-3p inhibits the progression of non-small cell lung cancer via inhibiting the activation of wnt/β-catenin signaling.
Wang Y; Wang L; Guo J; Zuo S; Wang Z; Hua S
Life Sci; 2021 Aug; 278():119573. PubMed ID: 33964297
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HIF-2α-Dependent NEAT1 Promotes the Progression of Non-Small Cell Lung Cancer through miR-101-3p/SOX9/Wnt/β-Catenin Signal Pathway.
Kong X; Zhao Y; Li X; Tao Z; Hou M; Ma H
Cell Physiol Biochem; 2019; 52(3):368-381. PubMed ID: 30845377
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis.
Wang D; Zhang S; Zhao M; Chen F
Cancer Med; 2020 Dec; 9(23):9138-9149. PubMed ID: 33146951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
